Janus Henderson Investors US’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $1.58M | Sell |
49,113
-4,223,218
| -99% | -$136M | ﹤0.01% | 945 |
|
|
2016
Q4 | $155M | Sell |
4,272,331
-408,129
| -9% | -$14.8M | 0.13% | 205 |
|
|
2016
Q3 | $215M | Buy |
4,680,460
+102,609
| +2% | +$4.72M | 0.18% | 159 |
|
|
2016
Q2 | $230M | Buy |
4,577,851
+568,998
| +14% | +$28.6M | 0.2% | 141 |
|
|
2016
Q1 | $215M | Buy |
4,008,853
+551,079
| +16% | +$29.5M | 0.19% | 142 |
|
|
2015
Q4 | $227M | Buy |
3,457,774
+200,003
| +6% | +$13.1M | 0.19% | 133 |
|
|
2015
Q3 | $184M | Buy |
3,257,771
+815,256
| +33% | +$46M | 0.17% | 165 |
|
|
2015
Q2 | $144M | Sell |
2,442,515
-418,657
| -15% | -$24.7M | 0.12% | 236 |
|
|
2015
Q1 | $178M | Buy |
2,861,172
+705,516
| +33% | +$44M | 0.15% | 202 |
|
|
2014
Q4 | $124M | Sell |
2,155,656
-504,635
| -19% | -$29M | 0.11% | 247 |
|
|
2014
Q3 | $143M | Buy |
2,660,291
+353,667
| +15% | +$19M | 0.13% | 214 |
|
|
2014
Q2 | $121M | Buy |
2,306,624
+546,016
| +31% | +$28.6M | 0.11% | 228 |
|
|
2014
Q1 | $93M | Buy |
1,760,608
+1,319,650
| +299% | +$69.7M | 0.09% | 284 |
|
|
2013
Q4 | $17.7M | Buy |
440,958
+139,458
| +46% | +$5.59M | 0.02% | 559 |
|
|
2013
Q3 | $11.4M | Buy |
301,500
+25,355
| +9% | +$958K | 0.01% | 623 |
|
|
2013
Q2 | $10.8M | Buy |
+276,145
| New | +$10.8M | 0.01% | 604 |
|